Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy
Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Purpose: To evaluate the efficacy of intravitreal bevacizumab (IVB) on focal edema with hard
exudates secondary to diabetic retinopathy.
Design: Prospective interventional case series. Participants: Ten eyes of 10 consecutive
patients showing focal edema with hard exudates secondary to diabetic retinopathy which are
not eligible for focal laser photocoagulation due to central location (< 500 µm from fovea).